Mednet Logo
CommunityMedical Oncology

How do you define cisplatin ineligibility for muscle invasive bladder cancer?

1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · University of Washington School of Medicine
Answered on

We traditionally have been using the "Galsky criteria" published in 2011 based on consensus.

We have looked into possibly lower threshold for estimated GFR, e.g. 50 ml/min, and possibly cisplatin "split dose" on a per patient basis if otherwise a patient is fit: Koshkin et al., PMID 29576445.

Sometim...

Join for free or sign in to see the full answer